Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Oct 22 - Oct 27
GLP-1 receptor agonist vs aspirin for primary prevention of colorectal cancer: Evidence from a real-world head-to-head comparison
Implications for Compounding Pharmacies and Prescribers (and Outsourcing Facilities) The April 1 clarification, read alongside FDA's escalating enforcement posture since early 2026, may signal a maturing and increasingly restrictive regulatory environment for GLP-1 compounding
A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
US$ 24.75
US$ 24.87
US$ 27.73
US$ 23.08
